Oakworth Capital, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Oakworth Capital, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	BUY	$700.03 - $830.35 $13,300 - $15,776	19 New	19 $13,000
Q1 2022 Apr 11, 2022	SELL	$595.12 - $698.43 $44,634 - $52,382	-75 Reduced 9.59%	707 $494,000
Q4 2021 Feb 07, 2022	BUY	$543.48 - $670.97 $179,891 - $222,091	331 Added 73.39%	782 $494,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $210,094 - $249,231	366 Added 430.59%	451 $273,000
Q1 2021 Apr 30, 2021	BUY	$446.73 - $548.2 $37,972 - $46,597	85 New	85 $40,000
Q2 2019 Aug 02, 2019	SELL	$299.6 - $414.82 $12,583 - $17,422	-42 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $18,117 - $21,168	42	42 $21,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Oakworth Capital, Inc. with notifications on news.